Sign In
Buy ALDX
$1.86
+0.220 (+13.41%)
At Close: Jun 03, 2026
Aldeyra Therapeutics Reaches Agreement With FDA For Use Of RASP As Objective Sign For Treatment Of Dry Eye Disease
12:01pm, Thursday, 04'th Jun 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immun
Ironwood Pharmaceuticals (IRWD) Looks Good: Stock Adds 7.6% in Session
01:04pm, Wednesday, 03'rd Jun 2020
Ironwood Pharmaceuticals (IRWD) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
Aldeyra Therapeutics to Present at the Jefferies Virtual Healthcare Conference
12:00pm, Wednesday, 03'rd Jun 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference
3 “Strong Buy” Biotech Stocks Under $5 With Explosive Upside Potential
02:28pm, Wednesday, 27'th May 2020
Which stocks are leading the pack out on Wall Street? Biotechs. Understandably, investors have taken a more cautious approach when navigating the confused
3 “Strong Buy” Biotech Stocks Under $5 With Explosive Upside Potential
01:49pm, Wednesday, 27'th May 2020
Which stocks are leading the pack out on Wall Street? Biotechs. Understandably, investors have taken a more cautious approach when navigating the confused financial environment, but focus is locking i
20 Healthcare Stocks Moving In Thursday's Pre-Market Session
12:00am, Thursday, 21'st May 2020Covid Report: This Biotech Says Its Coronavirus Drug Topped Remdesivir
09:24pm, Wednesday, 20'th May 2020
Shares of Kindred Biosciences and Vaxart popped Wednesday after the drugmakers inked a manufacturing deal for a coronavirus vaccine tablet. Aldeyra is also planning to test a treatment.
Aldeyra Therapeutics' (ALDX) CEO Todd Brady on COVID-19 Development Update Conference Call - Transcript
06:40pm, Wednesday, 20'th May 2020
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) COVID-19 Development Update Conference Call May 19, 2020 08:10 AM ET Company Participants Joshua Reed – Chief Financial
The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
12:12pm, Wednesday, 20'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) * ADC Therapeutics SA (NYSE: ADCT) (IPOed May 15) * A
